This conference, with an expected attendance of 1,500 delegates, aims at developing a full overview of current scientific advances in the field of cervical cancer control. Highlighted topics concern diagnostic and prevention strategies including screening and HPV vaccination. The development and market launch of HPV vaccines is a key element to be taken into account in all future prevention programs.
The purpose of the conference is not only to elaborate guidance for clinical practice, but also to widen the discussion beyond the purely medical aspects and to address public education issues.

Main Objectives of Sessions

	A review of recent developments in HPV infection and cervical cancer prevention and control.
	Integrate the use of HPV prophylactic vaccines into clinical practice.
	Advising patients about the potential and limitations of HPV prophylactic vaccines.
	Understanding the impact of HPV prophylactic vaccines
	Implementation of guidelines for cervical disease; screening and management of cervical abnormalities.
	Apply HPV DNA testing to clinical practice in a rational and cost-effective way.
	List and assess different tools and techniques available in the field of HPV infection diagnosis and adapt the most appropriate strategies for patients.
	Anticipate trends in biomarkers and genotyping for diagnosis and prevention.
	Compare worldwide experience in the field of screening and prevention of cervical disease, including developed and developing countries.
	Apply skills to enable the improvement, expansion, and use of scientific data for decision making
	Determine the public health role of physicians in cervical cancer control: prevention through training, early detection, treatment and quality of life.
	Identify existing strategies and explore innovative community interventions for cervical cancer screening outreach and public education.

Pleminary Structure of the Conference

The meeting will be structured over 3 days:

Thursday, Oct 4, 2007:
Delegates can choose between two full day sessions:
- Training Course on HPV Infection in Clinical Practice
- Public Education Session on HPV Infection and Vaccine Prevention

Friday, Oct 5, 2007:
- Morning: Plenary session on
* Global Strategies for HPV Vaccination

- Afternoon: Concurrent scientific sessions on the following topics
* Cytopathology,
* HPV Screening
* Molecular Markers
* HPV Genotyping

Saturday, Oct 6, 2007:
- Morning: Plenary session on
* New Prevention Technologies in the HPV Vaccine Era

- Afternoon: Concurrent scientific sessions on the following topics:
* Cervical Cancer Control in Developing Countries
* Management of Abnormal Lesions
* Immunology
* Extra Cervical Sites.

Satellite Symposia
In addition to the Eurogin program, sponsored satellite symposia will present the most recent developments and emerging technologies in the field of HPV infection, cervical cancer control and related areas.

Target Audience

This meeting is designed for gynecologists, cytopathologists, dermatologists, virologists, microbiologists, oncologists, epidemiologists, pediatricians, GPs, directors of cervical cancer screening programs and public health authorities involved in genital infections and neoplasia, and in particular human papillomavirus infections and cervical cancer prevention.

******************************

EUROGIN 2007 is an international conference which offers an excellent opportunity to meet your colleagues and peers to discuss the most important matters facing their practice in cervical cancer control.

CONFERENCE VENUE

The EUROGIN 2007 conference will be held in Monte Carlo - MONACO, at the

GRIMALDI FORUM
10 avenue Princesse Grace
MC 98001 MONACO
www.grimaldiforum.com

International airport: NICE Côte d'Azur (France) - 1 hour by taxi or shuttle bus.

The "GRIMALDI FORUM" is a very modern convention center located next to the seashore and one of the most prestigious European venues for international conventions.

Registration

The registration rates are as follows:

(in Euros)	Standard Rate	Students, Residents, Eastern Europe, Developing Countries
Early registration (before March 31, 2007)	500	350
After March 31, 2007	600	400
After September 1, 2007	680	480

This includes:

- Access to all sessions of the meeting

- Coffee breaks

- Program and presentation handouts

Online registration will open here soon.

Accommodation

The conference organizers have blocked a substantial number of rooms at preferential rates for conference participants (3 and 4 star hotels).

Detailed information and online hotel reservation will be made available here soon.


Any questions?

Should you have any questions, please contact Peter Mattonet at:
Phone: +33-1.48.88.96.24 or +33-1.44.40.01.20): on Tuesdays 14.30 - 18.30 or Thu 9.30 - 18.30 (Paris time)
Fax: +33-1.47.66.74.70
E-mail: peter.mattonet@eurogin.com